Comparison of Contrast-Enhanced Mammography and Contrast-Enhanced Breast MR Imaging.

Contrast-enhanced mammography (CEM) is a contrast-enhanced modality for breast cancer detection that utilizes iodinated contrast and dual-energy imaging performed on a digital mammography unit with only slight modifications. It is approved by the US Food and Drug Administration, commercially available, and in routine clinical use at centers around the world. It has similar sensitivity and specificity to MR Imaging and has advantages in terms of cost, patient acceptability, and examination time. MR Imaging has some advantages compared with CEM, especially in its ability to image the complete axilla and the chest wall.

[1]  Maximilian Reiser,et al.  Prospective multicenter cohort study to refine management recommendations for women at elevated familial risk of breast cancer: the EVA trial. , 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[2]  Yu-Ching Lin,et al.  Dual-Energy Contrast-Enhanced Spectral Mammography: Enhancement Analysis on BI-RADS 4 Non-Mass Microcalcifications in Screened Women , 2016, PloS one.

[3]  Joachim E. Wildberger,et al.  Contrast-enhanced spectral mammography in patients referred from the breast cancer screening programme , 2014, European Radiology.

[4]  Barbara A Pockaj,et al.  Potential Cost Savings of Contrast-Enhanced Digital Mammography. , 2017, AJR. American journal of roentgenology.

[5]  J. Wildberger,et al.  Evaluation of low-energy contrast-enhanced spectral mammography images by comparing them to full-field digital mammography using EUREF image quality criteria , 2015, European Radiology.

[6]  P. Slanetz,et al.  Workflow Considerations for Incorporation of Contrast-Enhanced Spectral Mammography Into a Breast Imaging Practice. , 2018, Journal of the American College of Radiology : JACR.

[7]  Janice S. Sung,et al.  Comparison of screening CEDM and MRI for women at increased risk for breast cancer: A pilot study. , 2017, European journal of radiology.

[8]  L Li,et al.  Contrast-enhanced spectral mammography (CESM) versus breast magnetic resonance imaging (MRI): A retrospective comparison in 66 breast lesions. , 2017, Diagnostic and interventional imaging.

[9]  B. Hamm,et al.  Contrast-enhanced spectral mammography vs. mammography and MRI – clinical performance in a multi-reader evaluation , 2017, European Radiology.

[10]  Tsung-Lung Yang,et al.  Clinical evaluation of contrast-enhanced digital mammography and contrast enhanced tomosynthesis--Comparison to contrast-enhanced breast MRI. , 2015, European journal of radiology.

[11]  M. Krohn,et al.  Contrast-enhanced spectral mammography versus MRI: Initial results in the detection of breast cancer and assessment of tumour size , 2013, European Radiology.

[12]  A. Miller,et al.  Periodic Screening for Breast Cancer: The Health Insurance Plan Project and its Sequelae, 1963–1986 , 1989 .

[13]  Michael A. Paolini,et al.  Gadolinium Deposition in Human Brain Tissues after Contrast-enhanced MR Imaging in Adult Patients without Intracranial Abnormalities. , 2017, Radiology.

[14]  R. Fimmers,et al.  Mammography, breast ultrasound, and magnetic resonance imaging for surveillance of women at high familial risk for breast cancer. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[15]  Janice S Sung,et al.  Bilateral contrast-enhanced dual-energy digital mammography: feasibility and comparison with conventional digital mammography and MR imaging in women with known breast carcinoma. , 2013, Radiology.

[16]  Janet Waters,et al.  MRI for breast cancer screening, diagnosis, and treatment , 2011, The Lancet.

[17]  D. Taylor,et al.  Could parenchymal enhancement on contrast-enhanced spectral mammography (CESM) represent a new breast cancer risk factor? Correlation with known radiology risk factors. , 2017, Clinical radiology.

[18]  Janice S Sung,et al.  Low energy mammogram obtained in contrast-enhanced digital mammography (CEDM) is comparable to routine full-field digital mammography (FFDM). , 2014, European journal of radiology.

[19]  Luca Braglia,et al.  Contrast-enhanced spectral mammography in neoadjuvant chemotherapy monitoring: a comparison with breast magnetic resonance imaging , 2017, Breast Cancer Research.

[20]  P. Slanetz,et al.  Contrast-enhanced spectral mammography (CESM) versus MRI in the high-risk screening setting: patient preferences and attitudes. , 2017, Clinical imaging.

[21]  Edward Hendrick,et al.  Comparison between Breast MRI and Contrast-Enhanced Spectral Mammography , 2015, Medical science monitor : international medical journal of experimental and clinical research.

[22]  S. Edge,et al.  Suspect breast lesions: findings at dynamic gadolinium-enhanced MR imaging correlated with mammographic and pathologic features. , 1995, Radiology.

[23]  G. Newstead,et al.  MR imaging of the breast. , 1995, Radiology.

[24]  Serge Muller,et al.  Dual-energy contrast-enhanced digital mammography: initial clinical results , 2011, European Radiology.

[25]  Ping Yang,et al.  Diagnostic Value of Contrast‐Enhanced Spectral Mammography for Screening Breast Cancer: Systematic Review and Meta‐analysis , 2018, Clinical breast cancer.

[26]  John M Lewin,et al.  Dual-energy contrast-enhanced digital subtraction mammography: feasibility. , 2003, Radiology.

[27]  J. Sayre,et al.  Newly Diagnosed Breast Cancer: Comparison of Contrast-enhanced Spectral Mammography and Breast MR Imaging in the Evaluation of Extent of Disease. , 2017, Radiology.

[28]  J. Kaplan,et al.  Comparison of Background Parenchymal Enhancement at Contrast-enhanced Spectral Mammography and Breast MR Imaging. , 2017, Radiology.

[29]  Yun-Chung Cheung,et al.  Diagnostic performance of dual-energy contrast-enhanced subtracted mammography in dense breasts compared to mammography alone: interobserver blind-reading analysis , 2014, European Radiology.

[30]  C A Kelsey,et al.  Effects of age, breast density, ethnicity, and estrogen replacement therapy on screening mammographic sensitivity and cancer stage at diagnosis: review of 183,134 screening mammograms in Albuquerque, New Mexico. , 1998, Radiology.

[31]  Matthew F. Covington,et al.  Contrast-Enhanced Spectral Mammography is Comparable to MRI in the Assessment of Residual Breast Cancer Following Neoadjuvant Systemic Therapy , 2018, Annals of Surgical Oncology.

[32]  D. Taylor,et al.  Contrast‐enhanced spectral mammography (CESM) and contrast enhanced MRI (CEMRI): Patient preferences and tolerance , 2015, Journal of medical imaging and radiation oncology.

[33]  B. Pockaj,et al.  Contrast-Enhanced Digital Mammography in the Surgical Management of Breast Cancer , 2016, Annals of Surgical Oncology.

[34]  L. Tabár,et al.  REDUCTION IN MORTALITY FROM BREAST CANCER AFTER MASS SCREENING WITH MAMMOGRAPHY Randomised Trial from the Breast Cancer Screening Working Group of the Swedish National Board of Health and Welfare , 1985, The Lancet.

[35]  Paola Clauser,et al.  Mammography: an update of the EUSOBI recommendations on information for women , 2016, Insights into Imaging.

[36]  T. Landberg,et al.  Mammographic screening and mortality from breast cancer: the Malmö mammographic screening trial. , 1988, BMJ.